DR. BAHADIR ON MEDIA
Who is Dr. MEHMET ILTEBER BAHADIR?
He was born in Antalya in 1971. He completed his primary and secondary education at Barbaros Elementary School (Antalya) and Antalya Anatolian High School, respectively. He studied at Istanbul University Medical Faculty between 1989-1996. He participated in Ministry of Health trainings on Mesotherapy and Ozone Therapy. He served in the Leukemic Children's Foundation and 112 emergency response teams. He practiced medicine in many private hospitals.
He is among the physicians who enabled phytoterapy to take hold in Turkey in 2009 and led the way in this regard. Between 2009-2014, he was responsible for R&D and production at Turkey's most prestigious Herbal Food Supplement company. During this period, he made many overseas visits, especially to China and Far Eastern countries, to improve his work. He was among the first physicians in Turkey to receive the Phytoterapy Certificate issued by the Ministry of Health. He has appeared on national and local TV channels in programs on phytoterapy and psoriasis. To date, over 6,000 improved patient cases (before and after) have been published.
He has been serving patients with psoriasis, chronic eczema, lichen planus, ichthyosis and rheumatic diseases that cause the upper skin to peel, in his clinic for approximately 11 years. During this time, he has applied treatments, skin ozonation and skin care programs to many of his patients. The most important feature of these applications is that no chemical or biological agents are used and there are no side effects. All patients are followed up with check-ups every 4 months for 2 years, and their treatments are monitored. Those who cannot come update their status with photographs.
The clinic is at the forefront of patient treatment and monitoring centers for psoriasis, chronic eczema, lichen planus and ichthyosis in our country and worldwide. Patients come from European countries like the UK, Germany, Bulgaria, and Asian countries like Azerbaijan, Korea, and Arab countries like Iraq, Syria, Kuwait, Qatar, Dubai. So far, he has been a guest on nearly 100 health programs and the main news bulletins of the country's most prestigious TV channels.
During the pandemic, while assistant specialists provided remote support to patients, the doctor himself dealt personally with each new patient and their special file.
Thanks to Dr. Bahadir's personal skin care recommendations, thousands of patients from all over the world are regaining healthy lives today.
AREAS OF INTEREST
OUR CLINIQUE RULES TO FOLLOW
FOR ALL OUR PATIENTS UNDE THE TREATMENT
How should patients apply creams for body and wound care?
What should psoriasis patients pay attention to when applying cream to lesions?
Psoriasis, Eczema, Rheumatism, Hashimato Thyroiditis, Ulcerative Colitis, Ankylosing Spondylitis
fall under the same category of diseases
Psoriasis, Eczema, Rheumatism, Hashimato Thyroiditis, Ulcerative Colitis, Ankylosing Spondylitis are sibling diseases. That is, if someone comes to us as a psoriasis patient, in later years the biggest sibling Rheumatism will likely be added. After age 40, 60% of patients treated at our clinic have rheumatism, and over the years even 2nd, 3rd and 4th sibling diseases are added. It is not enough to just heal Psoriasis lesions. Because most of these patients have a very high likelihood of developing Rheumatic Diseases, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Hashimoto's Thyroiditis, Ulcerative Colitis, Crohn's even if their psoriasis does not recur. These diseases stem from the Immune System and are siblings of each other. If any one appears, over time the other diseases will be added. For this reason, even if the lesions of patients treated at our clinic heal and do not recur, we keep them under control for 2 years. It is not enough to just heal Psoriasis lesions if they do not recur. These patients must definitely be examined in terms of the Immune System and brought under control. Psoriasis and Eczema are systemic diseases stemming from the Immune System that pave the way for sibling diseases.